Adam Kaplin
Chief Tech/Sci/R&D Officer chez MYMD PHARMACEUTICALS, INC.
Fortune : 201 000 $ au 29/02/2024
Profil
Founder of MIRA Pharmaceuticals, Inc., Adam Kaplin currently is Chief Scientific Officer for MyMD Pharmaceuticals, Inc. Dr. Kaplin is also on the board of Cody Unser First Step Foundation and Director-Johns Hopkins Ketamine Clinic at The Johns Hopkins University.
In the past Dr. Kaplin held the position of President & Chief Science Officer at MIRA Pharmaceuticals, Inc.
Adam Kaplin received an undergraduate degree from Yale University and a doctorate from The Johns Hopkins University.
Détentions connues dans des sociétés publiques
Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
---|---|---|---|---|
03/08/2023 | 200 000 ( 1,35% ) | 201 000 $ | 29/02/2024 | |
21/06/2023 | 0 ( -.--% ) | - $ | 29/02/2024 |
Postes actifs de Adam Kaplin
Sociétés | Poste | Début |
---|---|---|
MYMD PHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | 18/12/2020 |
The Johns Hopkins University | Corporate Officer/Principal | 01/01/2002 |
Cody Unser First Step Foundation | Director/Board Member | 01/01/2005 |
Anciens postes connus de Adam Kaplin
Sociétés | Poste | Fin |
---|---|---|
MIRA PHARMACEUTICALS, INC. | Founder | 07/03/2024 |
Formation de Adam Kaplin
The Johns Hopkins University | Doctorate Degree |
Yale University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 2 |
---|---|
MYMD PHARMACEUTICALS, INC. | Health Technology |
MIRA PHARMACEUTICALS, INC. | Health Technology |
Entreprise privées | 1 |
---|---|
Cody Unser First Step Foundation |